Antibody

1,032개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,032 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleRochePhase 3

ZRC-3277 (Pertuzumab, Pertuzumab (ZRC-3277))

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

neoadjuvant (Pertuzumab, Pertuzumab (neoadjuvant))

HER2-positive Breast Cancer; Neoplasms · HER2

#HER2#Antibody#Preclinical#monoclonal-antibody#HER2-positiveBreastCancer+2
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab + trastuzumab + metronomic chemotherapy)

Elderly Metastatic Breast Cancer Population · Elderly Metastatic Breast Cancer Populat

#ElderlyMetastaticBreastCancerPop#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab/Trastuzumab/Hyaluronidase-zzxf)

Breast Cancer; Breast Neoplasm · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastCancer+2
Trials 1Status Recruiting
AntibodyLimited DatastaleMerus B.V.Phase 3

Petosemtamab (Petosemtamab)

Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase3#monoclonal-antibody#Merus
Trials 1Status Recruiting
AntibodyLimited DatastaleMerus B.V.Phase 2

pembrolizumab (Keytruda, Petosemtamab + Pembrolizumab)

Lung Cancer - Non Small Cell Squamous; Lung Cancer - Non Small Cell Non-Squamous · Lung Cancer - Non Small Cell Squamous

#LungCancer-NonSmallCellSquamous#Antibody#Phase2#monoclonal-antibody#LungCancer-NonSmallCellNon-Squam+1
Trials 1Status Recruiting
AntibodyLimited DatastaleLG ChemPhase 1

atezolizumab (Tecentriq, Phase 1b: LB-LR1109 and Atezolizumab)

Non-small Cell Lung Cancer(NSCLC); Head and Neck Squamous Cell Carcinoma(HNSCC) · Non-small Cell Lung Cancer(NSCLC)

#Non-smallCellLungCancerNSCLC#Antibody#Phase1#monoclonal-antibody#HeadandNeckSquamousCellCarcinoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleAbbViePhase 1

Pivekimab Sunirine (Pivekimab Sunirine)

Acute Myeloid Leukemia; Mixed Phenotype Acute Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#Antibody#Phase1#monoclonal-antibody#MixedPhenotypeAcuteLeukemia+1
Trials 1Status Recruiting
AntibodyLimited DatastaleGenelux CorporationPhase 2

Platinum-doublet with or without bevacizumab (Platinum-doublet with or without bevacizumab)

Ovarian Cancer; Peritoneal Carcinomatosis · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#monoclonal-antibody#PeritonealCarcinomatosis+1
Trials 1Status Active
AntibodyLimited DatastaleAIO-Studien-gGmbHPhase 2

trastuzumab (Herceptin, Post-operative treatment trastuzumab mono therapy)

Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach · Adenocarcinoma of the Gastroesophageal J

#AdenocarcinomaoftheGastroesophag#Antibody#Phase2#monoclonal-antibody#AdenocarcinomaoftheStomach+1
Trials 1Status Active
AntibodyLimited DatastaleEmory UniversityPhase 2

trastuzumab (Herceptin, Pre operativeTrastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#Emory
Trials 1Status Active
AntibodyLimited DatastaleUniversitätsklinikum KölnPhase 2

Nivolumab/Ipilimumab (Pre-Chemo-radio-immunotherapy Treatment, Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab))

Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases · Cervical Cancer ≥ FIGO IIB and or Lymph

#CervicalCancerFIGOIIBandorLymph#Antibody#Phase2#monoclonal-antibody#CervicalCancerFIGOIIBandorLymphN+1
Trials 1Status Discontinued
AntibodyLimited DatastaleCentre Leon BerardPhase 2

atezolizumab (Tecentriq, Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery)

Sarcoma,Soft Tissue · Sarcoma,Soft Tissue

#SarcomaSoftTissue#Antibody#Phase2#monoclonal-antibody#Sarcoma+2
Trials 1Status Recruiting
AntibodyLimited DatastaleCentre Leon BerardPhase 2

atezolizumab (Tecentriq, Pre-operative radiotherapy followed by surgery then 2 cycles of atezolizumab.)

Sarcoma,Soft Tissue · Sarcoma,Soft Tissue

#SarcomaSoftTissue#Antibody#Phase2#monoclonal-antibody#Sarcoma+2
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity Hospital Fattouma Bo…Approved

Preoperative Intra-lesional Bevacizumab Injection in primary pterygium (Preoperative Intra-lesional Bevacizumab Injection in primary pterygium)

Pterygium · Pterygium

#Pterygium#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Active
AntibodyLimited DatastaleUniversity Hospital, GhentApproved

Proactive TDM-based dosing of guselkumab (Proactive TDM-based dosing of guselkumab)

Psoriasis Vulgaris · Psoriasis Vulgaris

#PsoriasisVulgaris#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity Hospital, GhentApproved

Proactive TDM-based dosing of ixekizumab (Proactive TDM-based dosing of ixekizumab)

Psoriasis Vulgaris · Psoriasis Vulgaris

#PsoriasisVulgaris#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity Hospital, GhentApproved

Proactive TDM-based dosing of secukinumab (Proactive TDM-based dosing of secukinumab)

Psoriasis Vulgaris · Psoriasis Vulgaris

#PsoriasisVulgaris#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Recruiting
AntibodyLimited DatastaleHenan Cancer HospitalPreclinical

trastuzumab (Herceptin, Pyrotinib and Trastuzumab plus Vinorelbine)

HER2 Positive Breast Cancer · HER2

#HER2#Antibody#Preclinical#monoclonal-antibody#HER2PositiveBreastCancer+1
Trials 1Status Active
AntibodyLimited DatastaleFujian Medical University Union…Phase 2

trastuzumab (Herceptin, Pyrotinib+Trastuzumab+Capecitabine)

Breast Cancer; Adjuvant Therapy · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#AdjuvantTherapy+1
Trials 1Status Recruiting

38 / 52 pages

← PreviousNext →